We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ITW:NYSEIllinois Tool Works Inc. Analysis

Data as of 2026-04-11 - not real-time

$270.52

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Illinois Tool Works (ITW) is trading in a neutral technical environment, with the short‑term moving average hugging the longer‑term average and the MACD histogram turning positive, suggesting modest bullish momentum. The RSI sits in a middle range, indicating the stock is neither overbought nor oversold, while price is perched between a well‑defined support zone and a nearby resistance ceiling. Volatility over the past month is elevated but manageable, and the beta reading points to lower market sensitivity than many peers. On the fundamentals side, the company continues its impressive dividend‑king streak, delivering a sizable payout with a payout ratio comfortably below the threshold that would threaten cash flow, and it generates strong operating and free cash flow. However, a discounted cash‑flow model places fair value far below the current market price, implying limited upside and a potential overvaluation concern.
The consensus analyst view remains neutral, reflecting the blend of solid earnings growth, robust cash generation, and a premium valuation. The dividend yield remains attractive for income‑focused investors, yet the modest upside potential and elevated price relative to intrinsic estimates suggest a cautious stance. Overall, the stock appears best suited for investors seeking steady income and long‑term stability rather than aggressive price appreciation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram indicating short‑term momentum
  • Price near established support level
  • Strong dividend payout supporting investor demand

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Consistent earnings growth and cash flow generation
  • Dividend sustainability with moderate payout ratio
  • Valuation still above intrinsic estimates limiting upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Dividend‑king status providing reliable income
  • Robust operating margins and return on equity
  • Diversified global footprint reducing concentration risk

Key Metrics & Analysis

Financial Health

Revenue Growth4.10%
Profit Margin19.11%
P/E Ratio25.8
ROE93.72%
ROA17.05%
Debt/Equity285.52
P/B Ratio24.2
Op. Cash Flow$3.1B
Free Cash Flow$2.2B
Industry P/E30.9

Technical Analysis

TrendNeutral
RSI54.0
Support$254.41
Resistance$274.78
MA 20$263.15
MA 50$276.67
MA 200$260.28
MACDBullish
VolumeStable
Fear & Greed Index87.09

Valuation

Fair Value$92.54
Target Price$275.88
Upside/Downside1.98%
GradeOvervalued
TypeBlend
Dividend Yield2.38%

Risk Assessment

Beta0.72
Volatility22.13%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.